Title |
Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review
|
---|---|
Published in |
Breast Cancer, April 2012
|
DOI | 10.1007/s12282-012-0347-0 |
Pubmed ID | |
Authors |
Tadashi Kobayashi, Tamotsu Ichiba, Toshikazu Sakuyama, Yasuhiro Arakawa, Eijiroh Nagasaki, Keisuke Aiba, Hiroko Nogi, Kazumi Kawase, Hiroshi Takeyama, Yasuo Toriumi, Ken Uchida, Masao Kobayashi, Chihiro Kanehira, Masafumi Suzuki, Naomi Ando, Kazuhiko Natori, Yasunobu Kuraishi |
Abstract |
Metastatic breast cancer (MBC) is generally incurable. However, 10-20-year relapse-free survival of MBC is approximately 2%, implying that at least a small subset of MBC patients achieve prolonged survival. We therefore analyzed long-term outcome in a particular subset, i.e., oligometastatic breast cancer (OMBC). |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Canada | 1 | 1% |
Unknown | 78 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 12 | 15% |
Student > Ph. D. Student | 11 | 14% |
Researcher | 11 | 14% |
Student > Postgraduate | 9 | 11% |
Student > Doctoral Student | 7 | 9% |
Other | 19 | 24% |
Unknown | 11 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 52 | 65% |
Agricultural and Biological Sciences | 4 | 5% |
Engineering | 3 | 4% |
Sports and Recreations | 2 | 3% |
Computer Science | 1 | 1% |
Other | 6 | 8% |
Unknown | 12 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2018.
All research outputs
#3,332,026
of 23,975,976 outputs
Outputs from Breast Cancer
#38
of 614 outputs
Outputs of similar age
#21,522
of 166,245 outputs
Outputs of similar age from Breast Cancer
#1
of 7 outputs
Altmetric has tracked 23,975,976 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 614 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them